Hidradenitis Suppurativa Clinical Trials

376 clinical trials for Hidradenitis Suppurativa across international registries, including 91 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI — RECRUITING
• Regulation of Inflammatory Genes in Hidradenitis Suppurativa — RECRUITING
• Botulinum Toxin Therapy in Hidradenitis Suppurativa — RECRUITING
• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE2
• Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib — RECRUITING · PHASE3
• Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa — RECRUITING · PHASE1
• An Observational Study of Patients With Dermatologic Disease — RECRUITING
• A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa — RECRUITING · PHASE2
• Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population — RECRUITING
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) — RECRUITING · PHASE1
• An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS — RECRUITING · PHASE3
• Myriad™ Augmented Soft Tissue Reconstruction Registry — RECRUITING
• Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE4
• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. — RECRUITING · PHASE2
• The Safety and Efficacy of Roflumilast Foam in HS — RECRUITING · PHASE2
• A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE2
• Real-world Secukinumab Outcomes in Canadian HS Patients — RECRUITING
• Global Healthcare Study on Hidradenitis Suppurativa — RECRUITING
• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases — RECRUITING
• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE2
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE3
• Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. — RECRUITING · PHASE1
• A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE2
• Pelashield™ PainGuard™ vs Restrata® in HS Surgery — RECRUITING · NA
• A Study With CIT-013 in HS Patients — RECRUITING · PHASE2
• Radiotherapy for Refractory Hidradenitis Suppurativa — RECRUITING · NA
• A Study of LAD191 in Adults With Hidradenitis Suppurativa — RECRUITING · PHASE2
• Clinical and Biological Characteristics of Hidradenitis Suppurativa — RECRUITING
• Study on the role of life circumstances in the development and severity of hidradenitis suppurativa (acne inversa) and varicosis (varicose veins) — RECRUITING
• Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository — RECRUITING
• Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa — RECRUITING · PHASE2
• A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic — RECRUITING
• Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers — RECRUITING
• Multi-Country, Cross-Sectional Study to Characterize Real-World Burden of Disease in Adolescent and Adult Patients with Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa — RECRUITING
• A Study of Zasocitinib in Adults With Hidradenitis Suppurativa — RECRUITING · PHASE2
• Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea — RECRUITING
• The Ohio State University Dermatology Biorepository — RECRUITING
• Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa — RECRUITING · PHASE1
• A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa — RECRUITING
• Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. — RECRUITING · PHASE1
• Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia — RECRUITING
• A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa — RECRUITING · PHASE2
• A PHASE 2A, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NAV-240 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE HIDRADENITIS SUPPURATIVA — RECRUITING · PHASE2
• A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED TRIAL TO ASSESS EFFICACY AND SAFETY OF ZASOCITINIB IN MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2, DOSE-FINDING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SAR445399 IN PARTICIPANTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2, DOSE-FINDING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SAR445399 IN PARTICIPANTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA — RECRUITING · PHASE2
• Acne inversa: research on pathogenesis and preclinical testing of potential therapeutic approaches — RECRUITING
• A PHASE 2, DOSE RANGING, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BFB759 IN PATIENTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA (COMPASS 2 - HS) — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSERANGING PHASE 2 STUDY OF BRIVEKIMIG FOLLOWED BY A MAINTENANCE PERIOD IN PARTICIPANTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA — RECRUITING · PHASE2
• 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa) — RECRUITING · PHASE1

Refine this search